Florida AG Subpoenas CVS Health in Probe of Pharmacy-PBM Steering
CVS sits 72% above its 52-week low of $58.5.
Summary
The Florida Attorney General has issued a subpoena to CVS Health, initiating a probe into whether its pharmacy benefit manager (PBM) business steers patients to its own pharmacies and offers preferential reimbursement rates. This investigation adds to the bipartisan scrutiny facing the PBM industry regarding potential market manipulation and its impact on independent pharmacies and consumer costs. The subpoena demands documents and testimony by July 28, signaling a formal legal and regulatory risk for CVS Health's core business model. This could lead to significant operational changes or financial penalties, impacting the company's substantial Florida operations.
At the time of this announcement, CVS was trading at $100.82 on NYSE in the Trade & Services sector, with a market capitalization of approximately $129.6B. The 52-week trading range was $58.50 to $103.12. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.